ArticleInternational journal of molecular sciences2020
Isolation and Characterization of the Novel Bacteriophage AXL3 against
Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.
- Pooled it
- Genomic analysis of prophages from Burkholderia gladioli exposes extensive genetic diversity.BMC genomics · 2026Article
- Therapeutic Potential of a NovelInternational journal of molecular sciences · 2026Article
- AFrontiers in microbiology · 2026Article
- A flagella-dependentmBio · 2025Article
- Enhanced suppression ofAntimicrobial agents and chemotherapy · 2025Article
- Characterization of the novel cross-genus phage vB_SmaS_QH3 and evaluation of its antibacterial efficacy againstFrontiers in microbiology · 2025Article
- Prophylactic phage biocontrol preventsApplied and environmental microbiology · 2024Article
- Enhanced Suppression ofbioRxiv : the preprint server for biology · 2024Article
- New Antimicrobial Strategies to Treat Multi-Drug Resistant Infections Caused by Gram-Negatives in Cystic Fibrosis.Antibiotics (Basel, Switzerland) · 2024Review
- Article
- Jojan: a novel virus that lyses Stenotrophomonas maltophilia from dog.Virus genes · 2023Article
- A guide toFrontiers in cellular and infection microbiology · 2023Review
- NovelPharmaceutics · 2022Article
- Isolation and characterization of the novel bacteriophage vB_SmaS_BUCT626 against Stenotrophomonas maltophilia.Virus genes · 2022Article
- Isolation and Characterization of the LyticViruses · 2022Article
- Characterization of Stenotrophomonas maltophilia phage AXL1 as a member of the genus Pamexvirus encoding resistance to trimethoprim-sulfamethoxazole.Scientific reports · 2022Article
- Article
- Characterization of the Bacteriophage BUCT603 and Therapeutic Potential Evaluation Against Drug-ResistantFrontiers in microbiology · 2022Article
- Potential application of a newly isolated phage BUCT609 infectingFrontiers in microbiology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
Abstract
The rapid increase in the number of worldwide human infections caused by the extremely antibiotic resistant bacterial pathogen
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.